Güray SAYDAM
Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, İç Hastalıkları Anabilim Dalı
Araştırma alanları: Sağlık Bilimleri, Tıp, Dahili Tıp Bilimleri, İç Hastalıkları, Hematoloji, Onkoloji, Temel Tıp Bilimleri, Tıbbi Biyoloji, Temel Bilimler, Yaşam Bilimleri
Yayınlar
- Real-world data on the use of asciminib in chronic-phase chronic myeloid leukemia after two or more prior tyrosine kinase inhibitors: Results of the Turkish managed access program along with a literature review (2026)
- Dose or Timing? The Role of Prophylaxis in Preventing Joint Bleeds in Hemophilia: A Cross-Generational Comparative Analysis (2026)
- Real-World Outcomes of Belinostat in Relapsed Refractory T-Cell Lymphomas: A Report from the Lymphoma Study Group of Turkish Society of Hematology (2026)
- FACIT-fatigue score and treatment quality assessment for paroxysmal nocturnal hemoglobinuria patients treated with Eculizumab in Türkiye (2026)
- Sensory and Clinical Characterization of Acute and Chronic Pain in Hemophilia: Identification of Distinct Pain Phenotypes (2026)
- Evaluation of the Correlation Between Hemoglobin, Albumin, Lymphocyte, and Platelet Score and Prognosis in Patients with Mantle Cell Lymphoma: Single Center Retrospective Study (2026)
- Clinical use and adverse effects of tyrosine kinase inhibitors in patients with chronic myeloid leukemia: The role of comorbidities (2026)
- Clinical use and adverse effects of tyrosine kinase inhibitors in patients with chronic myeloid leukemia: The role of comorbidities (2026)
- Clinical and Pathological Evaluation of CD5/SOX11 Status in Mantle Cell Lymphoma (2026)
- Targeting leukemic stem cells: enhanced eradication via tivantinib (ARQ197) and asciminib (ABL001) with molecular docking-guided screening of therapeutic derivatives (2025)
- Is it safe to perform coronary artery bypass grafting surgery in patients with hemophilia? A case series of four patients (2025)
- Practical Guidance on the Clinical Management of Belantamab Mafodotin for Patients With Relapsed/Refractory Multiple Myeloma: Recommendations From the Middle East and North Africa Expert Panel (2025)
- Exploring an independent association between rituximab‐cyclophosphamide‐doxorubicin‐vincristine‐prednisolone dose intensity and clinical outcomes in large B‐cell lymphoma: Analyses of subsequent endpoints following a complete response in a real‐world cohort of 1369 patients (2025)
- Otolog Kök Hücre Nakli Yapılan Hastalarda Sitomegalovirüs DNAemisinin Nüks ve Mortalite ile İlişkisi: Tek Merkezli Retrospektif Bir Çalışma (2025)
- Safety and efficacy of rilzabrutinib vs placebo in adults with immune thrombocytopenia: the phase 3 LUNA3 study (2025)
- Is it safe to perform coronary artery bypass grafting surgery in patients with hemophilia? A case series of four patients (2025)
- 664 | SIMPLIFIED MOLECULAR IPI AS ELIGIBILITY CRITERIA FOR CLINICAL TRIALS: ANALYSIS OF THE TURKISH LYMPHOMA STUDY GROUP’S LARGE B‐CELL LYMPHOMA COHORT (2025)
- 359 | UPDATED RESULTS FROM KEYNOTE‐B68: PEMBROLIZUMAB EVERY 6 WEEKS IN PARTICIPANTS WITH RELAPSED OR REFRACTORY CLASSIC HODGKIN LYMPHOMA OR PRIMARY MEDIASTINAL B‐CELL LYMPHOMA (2025)
- 318 | PHASE 2/3 waveLINE‐003 STUDY: ZILOVERTAMAB VEDOTIN PLUS STANDARD OF CARE IN RELAPSED OR REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA (2025)
- Simplified Molecular International Prognostic Index as an eligibility criterion for clinical trials: Analysis of the Turkish Lymphoma Study Group's large B‐cell lymphoma cohort (2025)
- POSTER: ABCL-373 Retrospecti?ve Analysis of Primary Breast Lymphomas: A Single-Center Experience (2025)
- A retrospective evaluation of chronic myeloid leukemia patients treated with imatinib (2025)
- Real-world outcomes and prognostic factors in primary mediastinal B-cell lymphoma: a multicenter study of 157 patients (2025)
- A Large Room for Improvement Concerning the Management of Relapsed Refractory Large B-cell Lymphoma in Türkiye: Real-World Outcomes in the Setting Without Access to T-Cell Redirecting Therapies (2025)
- Evaluation of Parenteral Nutrition Treatment In Hematological Oncology Patients in Terms of Appropriateness with ESPEN Guideline and Pharmacoeconomics (2024)
- Does immunohistochemical staining predict mobilization success in multiple myeloma patients? (2024)
- The assessment of health-related quality of life in patients with polycythemia vera (2024)
- Systemic Mastocytosis in Adults: Long-Term Follow up and Real-Life Experience (2024)
- Mastositoz (2024)
- Yaşlanan hemofilik bireylerde yeni bir problem: Kanser (2024)
- Single agent vemurafenib or rituximab-vemurafenib combination for the treatment of relapsed/refractory hairy cell leukemia, a multicenter experience (2024)
- SURGICAL INTERVENTIONS IN FACTOR VII DEFICIENCY: A SINGLE CENTER EXPERIENCE (2024)
- The assessment of health-related quality of life in patients with polycythemia vera (2024)
- Incidental Diagnosis of Cyclic Thrombocytopenia: An Asymptomatic Case (2024)
- Real-Life Experience with Pomalidomide plus Dexamethasone in Patients with Multiple Myeloma: A Single Center Retrospective Study (2024)
- Evaluation of Socio-demographic Factors and Comorbidities in Adult Hemophilia Patients (2024)
- Is Obi-Benda-Len a New Chance for Relapsed or Refractory B-Cell Lymphoma Patients? (2024)
- ABCL-251 Case Report of Refractory Large B-Cell Lymphoma With IRF4 Rearrangement (2024)
- Nodüler Lenfosit Predominant Hodgkin Lenfoma Tedavisinde Rituksimab Temelli Rejimlerin Sağkalıma Katkısı (2024)
- A Novel Challenge in Elderly People with Hemophilia: Cancer (2024)
- A new scoring system to predict survival in elderly advanced stage Hodgkin lymphoma patients (2024)
- Does immunohistochemical staining predict mobilization success in multiple myeloma patients? (2024)
- Treatment Patterns and Clinical Outcomes in Patients with Hodgkin Lymphoma from Saudi Arabia, Türkiye, and South Africa: Subgroup Analysis from the International, Multi-center, Retrospective BHOLISTIC Study (2024)
- A Single-Center Retrospective Evaluation of The Incidence and Survival of Invasive Fungal Infection in Allogeneic Stem Cell Transplant Patients (2024)
- Primary Thyroid Lymphoma: A Nationwide Retrospective Cohort Analysis of Survival and Determinant Factors (2023)
- Immune Thrombotic Thrombocytopenic Purpura in Elderly Patients: The Roles of PLASMIC and French Scores (2023)
- Adherence to hemophilia patients with prophylaxis: Veritas-Pro and psychometric properties adapted to Turkish (2023)
- Adult Onset Langerhans Cell Histiocytosis: Clinical Characteristics and Treatment Outcomes (2023)
- Adherence to hemophilia patients with prophylaxis: Veritas-Pro and psychometric properties adapted to Turkish (2023)
- Phase 2 KEYNOTE‐B68 study: pembrolizumab every 6 weeks in relapsed/refractory (R/R) classical Hodgkin lymphoma (cHL) or primary mediastinal B‐cell lymphoma (PMBCL) (2023)
- PB1937: A RARE, DIFFICULT- TO- DIAGNOSE DISEASE; LANGERHANS CELL HISTIOCYTOSIS – A SINGLE CENTRE EXPERIENCE (2023)
- P1073: A NEW SCORING SYSTEM TO PREDICT SURVIVAL IN ELDERLY ADVANCED STAGE HODGKIN LYMPHOMA PATIENTS: STUDY BY TURKISH SOCIETY OF HAEMATOLOGY LYMPHOMA ACADEMY WORKING GROUP (2023)
- PB2652: EVALUATION OF 6 CASES WITH FXIII DEFICIENCY: SINGLE CENTRE EXPERIENCE (2023)
- PB2645: HEMATURIA IN ADULT HAEMOPHILIC INDIVIDUALS: IS THE HEMAOPHILIA THE ONLY CAUSE OF HEMATURIA? A SINGLE CENTRE EXPERIENCE FOR A DECADE (2023)
- POSTER: CT-232 Evaluation of the Effects of Cytomegalovirus and BK Polyomavirus Infections on Overall Survival Following Allogeneic Stem Cell Transplantation: A Single Center Experience (2023)
- POSTER: MDS-145 A Successful Treatment of Relapsed/Refractory MDS Patient who is Followed Under Hemodialysis (2023)
- POSTER: ABCL-152 Evaluation of Safety Profile of Rituximab + Lenalidomide Protocol in Frail Elderly Relapsed/Refractory Diffuse Large B-Cell Lymphoma Patients (2023)
- POSTER: CT-129 A Rare, Challenging Disease: Langerhans Cell Histiocytosis, a Single-Center Experience (2023)
- ABCL-152 Evaluation of Safety Profile of Rituximab + Lenalidomide Protocol in Frail Elderly Relapsed/Refractory Diffuse Large B-Cell Lymphoma Patients (2023)
- POSTER: CT-127 Evaluation of Cytomegalovirus Infection/Disease Frequency and Risk Factors Following Allogeneic Stem Cell Transplantation: A Single Center Experience (2023)
- POSTER: CLL-147 Chronic Hepatitis B Infection Management During Long-Term Follow-Up of Chronic Lymphocytic Leukemia (CLL) Treated With Multiple Lines of Chemoimmunotherapy, Including Ibrutinib (2023)
- POSTER: MPN-149 Hemophilia and Gastrointestinal Bleeding: Beyond Hemarthrosis (2023)
- Immune Thrombotic Thrombocytopenic Purpura in Elderly Patients; the Role for PLASMIC and French Scores (2023)
- Experience of Daratumumab in Relapsed/Refractory Multiple Myeloma: A Multicenter Study from Türkiye (2023)
- Multimorbidities and polypharmacy in ageing hemophilia patients (2023)
- Detailed Analysis of Follicular Lymphoma over 25 Years: A Single-Center, Retrospective Study (2022)
- Complex karyotype with double Philadelphia chromosome and T315I mutation results in blastic phase and extensive extramedullary infiltration in a chronic myeloid leukemia patient. (2022)
- Clinicopathological characteristics, genetics and prognosis of patients with myeloid sarcoma: a single-center study. (2022)
- Relationship Between Severity of Renal Amyloid Deposition and Clinical Outcomes in Non-AA Amyloidosis (2022)
- A case with CD30 positive diffuse large B cell lymphoma. (2022)
- Evaluation of safety profile of rituximab + lenalidomide protocol in frail elder relapsed/refractory diffuse large B cell lymphoma patients. (2022)
- 19 years’ experiences of therapeutic apheresis center of Ege University Medical Faculty. (2022)
- ERİŞKİN HEMOFİLİK BİREYLERDE KANSER SIKLIĞI: TEK MERKEZ DENEYİMİ. (2022)
- Successful treatment of patients with acute myeloid leukemia and Myelodysplastic Syndrome by decitabine. (2022)
- Turkey real-life data: demographic features, treatment results and effects of comorbidities in chronic myeloid leukemia. (2022)
- Evaluation of cardiovascular disease risk factors, inflammatory markers and subclinical atherosclerosis in patients with hemophilia (2022)
- Origanum Sipyleum Methanol Extract in Combination with Ponatinib Shows Synergistic anti-Leukemic Activities on Chronic Myeloid Leukemia Cells (2022)
- CD5 as a prognostic marker in patients with diffuse large B-cell lymphoma: a multicenter study (2022)
- Successful treatment of patients with acute myeloid leukemia and Myelodysplastic Syndrome by decitabine (2022)
- Successful treatment of patients with acute myeloid leukemia and Myelodysplastic Syndrome by decitabine (2022)
- Ruxolitinib versus best available therapy in inadequately controlled polycythaemia vera without splenomegaly (RESPONSE-2): 5-year follow up of a randomised, phase 3b study (2022)
- Miyelodisplastik sendrom hastalığında P53 polimorfizmlerinin önemi (2022)
- Goiter Incidence in the Aegean Region and the Role of Drinking Water and Hereditary Factors in Goiter Development (2022)
- Effects of Commonly Prescribed Nonsteroidal Anti-inflamatory Drugs on Thyroid Hormone Measurements and TSH Response to TRH Test (2022)
- Miyelodisplastik Sendrom Hastalığında P53 Polimorfizmlerinin Önemi (2022)
- Survival in patients with multiple myeloma: evaluation of possible associations with bone marrow fibrosis and investigation of factors independently associated with survival (2022)
- Pralatrexate in patients with relapsed and refractory T-cell lymphomas: real world data (2022)
- The Effect of Comorbidities on the Choice of Tyrosine Kinase Inhibitors in Patients with Chronic Myeloid Leukemia (2022)
- A Case Series of CML Patients Who Were Presented with Isolated Thrombocytosis (2022)
- CD5 as a prognostic marker in patients with diffuse large B-cell lymphoma: a multicenter study (2022)
- Combination of dasatinib and okadaic acid induces apoptosis and cell cycle arrest by targeting protein phosphatase PP2A in chronic myeloid leukemia cells (2022)
- Comparative expression analysis of dasatinib and ponatinib-regulated lncRNAs in chronic myeloid leukemia and their network analysis (2022)
- Patient characteristics and management practices in chronic myeloid leukemia in Turkey: reflections from an expert meeting (2022)
- MANAGEMENT OF MAJOR SURGERY IN A PATIENT WITH TYPE 3 VON WILLEBRAND DISEASE WHO HAS LOW TITER INHIBITOR (2021)
- A Histopathological Scoring and Grading System for Renal Non-aa Amyloidosis: Prediction of Clinical Manifestations and Outcomes (2021)
- Multiple Myelom Hastalarında Serum Albümin Düzeyinin Kök hücre Mobilizasyonuna Etkisi (2021)
- Does Immunohistochemically CD5 Positivity Matter In Diffuse Large B-Cell Lymphoma Patients? Turkish Multicenter Study (2021)
- PI3K/mTOR dual-inhibition with VS-5584 enhances anti-leukemic efficacy of ponatinib in blasts and Ph-negative LSCs of chronic myeloid leukemia (2021)
- Evolution of clinical characteristics of patients with paroxysmal nocturnal hemoglobinuria treated with eculizumab in turkey: a multicenter retrospective analysis (2021)
- Miyelodisplastik Sendromda Kromozomal Yeniden Düzenlemelerin Tespiti: Standart Karyotip Ve Fish Yöntemleri Arasinda Karşilaştirma (2021)